PUBLISHER: The Business Research Company | PRODUCT CODE: 2098658
PUBLISHER: The Business Research Company | PRODUCT CODE: 2098658
Ethylenediamine (EDA) and its derivatives are organic compounds containing two amine functional groups within their molecular framework, offering high chemical reactivity, strong metal-chelating properties, and excellent stability. These materials are extensively used as important intermediates in chemical manufacturing because of their capacity to form complex molecular architectures, improve formulation performance, and contribute to the development of advanced industrial and specialty chemical products.
The primary types of ethylenediamine (EDA) and its derivatives comprise ethylenediamine dihydrochloride, ethylenediamine tetraacetic acid, ethylenediamine-based derivatives, ethylenediamine salts, and pure ethylenediamine. Ethylenediamine dihydrochloride is a chemical compound produced from ethylenediamine and is extensively utilized across pharmaceutical, chemical, and industrial sectors. These products are segmented according to chemical formulations such as amine derivatives, chelating agents, surfactants, corrosion inhibitors, and bioplastics. They are applied in polymer manufacturing, metal processing, biocide production, paints and coatings, adhesives and sealants, and pharmaceutical intermediate production, serving end-use industries including chemicals, pharmaceuticals, agriculture, textiles, automotive, and cosmetics.
Tariffs are influencing the ethylenediamine (EDA) and derivatives market by increasing expenses associated with imported amine-based intermediates, chelating agents, and specialty chemical feedstocks, resulting in higher production costs across multiple applications including polymer manufacturing, metal treatment processes, and pharmaceutical production. This is especially affecting ethylenediamine derivatives, EDTA-based compounds, and related salt formulations, with Asia-Pacific and Europe experiencing disruptions due to dependence on imported high-purity inputs. The chemicals, pharmaceuticals, and agriculture sectors are the most impacted due to their sensitivity to raw material cost fluctuations. At the same time, tariffs are encouraging the expansion of domestic amine derivative production, diversification of supply sources, and investment in localized specialty chemical manufacturing facilities, improving long-term supply security.
The ethylenediamine (EDA) and derivatives market size has grown strongly in recent years. It will grow from $1.77 billion in 2025 to $1.91 billion in 2026 at a compound annual growth rate (CAGR) of 8.3%. The historical-period growth can be attributed to increasing chemical intermediate manufacturing, rising demand for chelating agents in industrial applications, expansion of pharmaceutical synthesis processes, growing utilization of corrosion inhibitors in infrastructure development, and advancement in agrochemical formulations using amines.
The ethylenediamine (EDA) and derivatives market size is expected to see strong growth in the next few years. It will grow to $2.65 billion in 2030 at a compound annual growth rate (CAGR) of 8.5%. The growth in the forecast period can be attributed to the expansion of specialty chemical demand in advanced industries, increasing need for sustainable water treatment solutions, rising development of biodegradable chelating agent alternatives, growing pharmaceutical pipelines involving complex molecules, and advancements in high-efficiency polymer and resin technologies. Major trends in the forecast period include expanding applications of ethylenediamine-based chelating agents in water treatment systems, increasing demand for high-performance corrosion inhibitors in industrial applications, growth in EDTA and its derivative usage in agricultural micronutrient formulations, rising adoption of polyamine derivatives in polymer and resin manufacturing, and development of high-purity amine intermediates for pharmaceutical synthesis.
The increasing pharmaceutical production is expected to drive the growth of the ethylenediamine (EDA) and derivatives market going forward. Pharmaceutical production refers to the industrial process of manufacturing medicinal drugs and therapeutic products through formulation, synthesis, processing, and quality control to ensure they are safe, effective, and suitable for patient use. The rising level of pharmaceutical production is mainly attributed to growing global healthcare demand, which necessitates higher volumes of medicines to address the increasing need for treatment and healthcare services across the world. Ethylenediamine (EDA) and its derivatives are useful in pharmaceutical production as they function as key intermediates in the synthesis of active pharmaceutical ingredients (APIs), supporting the development of stable and high-purity drug compounds with enhanced therapeutic efficacy. For instance, in April 2025, according to Eurostat, a Luxembourg-based government agency, in 2024, EU exports of medicinal and pharmaceutical products increased by 13.5% compared with 2023, reaching $316.38 billion (€313.4 billion). At the same time, imports only recorded a modest increase of 0.5%, amounting to $112.7 billion (€119.7 billion). Therefore, the increasing pharmaceutical production is driving the growth of the ethylenediamine (EDA) and derivatives market.
The expanding textile industry is expected to drive the growth of the ethylenediamine (EDA) and derivatives market going forward. The textile industry refers to the sector involved in the production, processing, and manufacturing of fibers, yarns, fabrics, and finished clothing and textile products. The expansion of the textile industry is driven by rising demand for apparel, as a growing population increases the need for clothing, thereby boosting production across the textile value chain. Ethylenediamine (EDA) and its derivatives support the textile industry by serving as important intermediates in the production of dyes, resins, and fabric softening agents that improve color performance, durability, and overall textile finishing quality. For instance, in June 2025, according to Textile Industries Media Group LLC, a US-based publishing company, the value of U.S. shipments of man-made fiber, textiles, and apparel was approximately $63.9 billion in 2024, compared with $64.8 billion in 2023. Therefore, the expanding textile industry is driving the growth of the ethylenediamine (EDA) and derivatives market.
The increasing construction and infrastructure activities are expected to drive the growth of the ethylenediamine (EDA) and derivatives market going forward. Construction and infrastructure activities refer to the development, expansion, and maintenance of buildings, roads, bridges, and other physical structures that support economic and social functions. The rise in construction and infrastructure activities is driven by rapid urbanization, as growing population migration toward cities increases demand for residential buildings, transportation systems, and essential public infrastructure. Ethylenediamine (EDA) and its derivatives enhance construction and infrastructure activities by improving the performance, durability, and chemical resistance of construction materials such as epoxy coatings, adhesives, and concrete additives, enabling stronger and longer-lasting structures. For instance, in July 2023, according to the Australian Bureau of Statistics, an Australia-based government administration, the number of dwellings under construction in the March quarter of 2023 increased by 1.3% to 240,813 units, surpassing the previous record of 240,065 units reported in the March 2022 quarter. Therefore, the growing construction and infrastructure activities are driving the growth of the ethylenediamine (EDA) and derivatives market.
Major companies operating in the ethylenediamine (EDA) and derivatives market are BASF SE, The Dow Chemical Company, Huntsman Corporation, Nouryon, Tosoh Corporation, Delamine BV, Saudi Basic Industries Corporation (SABIC), Mitsui Chemicals Inc., Arkema Group, Eastman Chemical Company, LANXESS AG, Oriental Union Chemical Corp., Alkyl Amines Chemicals Limited, Shandong Lianmeng Chemical Group Co. Ltd., Amines And Plasticizers Limited, Prasol Chemicals Private Limited, Diamines and Chemicals Limited, Yantai Jinhai Chemicals Co. Ltd., Balaji Specialty Chemicals Limited, Celanese Corporation, Evonik Industries AG
Asia-Pacific was the dominant region ethylenediamine (EDA) and derivatives in the market in 2025 and is expected to be the rapidly expanding region in the forecast period. The regions covered in ethylenediamine (EDA) and derivatives report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the ethylenediamine (EDA) and derivatives market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The ethylenediamine (EDA) and derivatives market consists of sales of ethylenediamine, diethylenetriamine (DETA), and triethylenetetramine (TETA). Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or producers of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the producers of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
The ethylenediamine (EDA) and derivatives market research report is one of a series of new reports from The Business Research Company that provides ethylenediamine (EDA) and derivatives market statistics, including ethylenediamine (EDA) and derivatives industry global market size, regional shares, competitors with a ethylenediamine (EDA) and derivatives market share, detailed ethylenediamine (EDA) and derivatives market segments, market trends and opportunities, and any further data you may need to thrive in the ethylenediamine (EDA) and derivatives industry. This ethylenediamine (EDA) and derivatives market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Ethylenediamine (EDA) And Derivatives Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses ethylenediamine (eda) and derivatives market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for ethylenediamine (eda) and derivatives ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The ethylenediamine (eda) and derivatives market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.